Category Archives for university hospital
Multiple Myeloma Side Effects- Prevent, Heal Chemobrain
“This is the first study that puts chemo brain on a sound scientific footing, in terms of neurobiology and cellular biology.” After years of denials, excuses and stalling from conventional oncology
Continue readingMultiple Myeloma Symptom, Side Effect- Thick blood, ESR Rate, Blood Clots
“Multiple myeloma is associated with a significant risk of venous thromboembolism (VTE-blood clot), causing substantial levels of morbidity and mortality.” Thick blood, documented by a high
Continue readingMultiple Myeloma Side Effect- Cardiomyopathy- LifeTime Risk of Heart Failure
“Once HF symptoms appear (stage C HF) in patients with reduced LVEF, the risk for progression to stage D HF increases, with a recent study of 964 HF with reduced EF patients…” I am a
Continue readingEnd-Stage Multiple Myeloma- Magic Mushrooms?
“Therefore, it is not surprising that patients may experience a diagnosis of cancer as sudden, catastrophic, and/or life-threatening.” Not all cancer diagnoses are alike. I’m not minimizing
Continue readingRevlimid, Multiple Myeloma, Secondary Cancer
“…various types of therapies (eg, oral alkylating therapy, myeloablative therapy used in conjunction with ASCT, radiotherapy, and revlimid (lenalidomide) to be associated with an excess of
Continue readingMultiple Myeloma Symptom, Side Effect- Heart Failure
“MM can cause cardiac comorbidities such as cardiomyopathy and heart failure caused by cardiac amyloidosis and/or anemia. Some of the treatments used in MM can also affect cardiovascular health…” According
Continue readingBone Imaging Can Make or Break Multiple Myeloma
Bone imaging is a critical aspect of care for patients with multiple myeloma (MM), and recent advances in imaging modalities have improved detection of lytic lesions and bone marrow involvement. “Bone
Continue readingMultiple Myeloma Symptom, Side Effect- Infection
“We show that the risk of infections and infection-related death is significantly increased in MM patients compared to controls.” Myelosuppression is the most common cause of death (COD) among
Continue readingMultiple Myeloma Treatment- Long-term Bone Marrow Injury
“Long-term Bone Marrow (LT-BM) injury is a common cancer treatment-related late effect caused by IR- and chemotherapy-induced damage to HSCs.” Conventional multiple myeloma treatment is fraught
Continue readingAutologous Stem Cell Transplant- NO OVERALL SURVIVAL for Myeloma
These results were confirmed by a meta-analysis that showed a significant benefit for HDT/ASCT in terms of EFS but no benefit in terms of OS (in myeloma)...” The standard-of-care (SOC) for newly
Continue reading